Lyell Immunopharma Inc. (LYEL)
NASDAQ: LYEL
· Real-Time Price · USD
10.62
-0.14 (-1.30%)
At close: Aug 15, 2025, 3:59 PM
10.58
-0.38%
After-hours: Aug 15, 2025, 04:10 PM EDT
Lyell Immunopharma Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -42.68M | -52.2M | -191.94M | -44.58M | -45.81M | -60.67M | -52.93M | -50.85M | -63.89M | -66.96M | -8.4M | -70.25M | -36.32M | -68.14M | -83.71M | -48.88M | -62.59M | -55.04M |
Depreciation & Amortization | 3.13M | 3.44M | 5.03M | 4.68M | 4.9M | 5.02M | 5.06M | 5.1M | 5.06M | 5.03M | 5.04M | 4.62M | 4.17M | 4.19M | 4.57M | 4.09M | 3.01M | 1.96M |
Stock-Based Compensation | 5M | 6.02M | 8.08M | 7.62M | 8.28M | 9.15M | 8.46M | 10.52M | 14.22M | 13.88M | 18.36M | 19.12M | 22.41M | 22.03M | 21.18M | 13.04M | 15.25M | 12.73M |
Other Working Capital | n/a | -7.9M | 2.07M | 1.6M | -437K | -3.12M | 1.3M | 3.84M | 3.2M | -6.38M | -42.87M | 1.73M | -35.74M | -5.33M | 3.52M | 6.73M | -911K | -5.41M |
Other Non-Cash Items | 87K | -2.45M | 131.55M | -3.8M | 14.09M | 27.02M | 15.21M | -3.23M | 582K | 6.15M | -105.78M | 7.66M | 3.15M | -3.53M | -16.2M | -619K | 9.96M | 11.49M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | -18.15M | -1.65M | 1.28M | n/a | 93.9M | n/a | n/a | n/a | 37.38M | 1.09M | 996K | 43K |
Change in Working Capital | n/a | -9.55M | 34K | 1.04M | -954K | -3.24M | 1.72M | 2.43M | 3.58M | -4.31M | -43.39M | 1.75M | -37.98M | -2.39M | 3.62M | 5.74M | -565K | -4.78M |
Operating Cash Flow | -34.46M | -54.74M | -47.24M | -35.04M | -38.09M | -42.02M | -40.63M | -37.69M | -39.16M | -46.21M | -40.27M | -37.1M | -44.33M | -47.85M | -33.17M | -25.53M | -33.95M | -33.6M |
Capital Expenditures | -168K | -246K | -44K | -59K | -331K | -30K | -25K | -195K | -933K | -1.53M | -4.58M | -2.79M | -7.17M | -9.73M | -10.27M | -11.6M | -24.45M | -19.19M |
Cash Acquisitions | n/a | n/a | -31.35M | n/a | n/a | n/a | 100.67M | 78.28M | 33.26M | -33.69M | n/a | 160.79M | n/a | 96.2M | -40K | n/a | 40K | n/a |
Purchase of Investments | -80.7M | -84.41M | -38.8M | -131.43M | -116.46M | -108.01M | -256.79M | -78.28M | -33.26M | -108.56M | -220.46M | -160.79M | -89.66M | -96.2M | -673.47M | -275.31M | -215.94M | -48.29M |
Sales Maturities Of Investments | 93.52M | 154.12M | 123.7M | 133.41M | 161.8M | 130.03M | 156.12M | 178.15M | 187.1M | 142.25M | 110.9M | 106.5M | 121.85M | 79.81M | 70.33M | 142.04M | 200.87M | 204.16M |
Other Investing Acitivies | n/a | n/a | n/a | n/a | 45.34M | 22.02M | -100.67M | -78.28M | -33.26M | 33.69M | 160.79M | -160.79M | 32.19M | -96.2M | 539.5M | -275.31M | -215.9M | -48.29M |
Investing Cash Flow | 12.65M | 69.47M | 53.51M | 1.92M | 45.01M | 21.99M | -100.69M | 99.67M | 152.91M | 32.15M | 46.65M | -57.09M | 25.02M | -26.12M | -73.9M | -144.87M | -39.47M | 136.68M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | 36.01M | -734K | 810K | -76K | -123K | -215K | -50K | -69K | -94K | -367K | n/a | n/a | n/a | -531K | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 183K | 1K | n/a | n/a | 862K | 27K | 759K | -143K | 1.2M | -69K | 863K | 4.76M | 2.46M | 2.56M | 7.4M | 529K | 630K | 884K |
Financial Cash Flow | 183K | 1K | 437K | n/a | 862K | 27K | 759K | -143K | 1.2M | -69K | 863K | 4.76M | 2.46M | 2.56M | 7.4M | -531K | 393.49M | 884K |
Net Cash Flow | -21.63M | 14.73M | 6.7M | -33.12M | 7.77M | -20M | -140.57M | 61.84M | 114.95M | -14.13M | 7.24M | -89.43M | -16.86M | -71.42M | -99.68M | -170.94M | 320.07M | 103.96M |
Free Cash Flow | -34.63M | -54.98M | -47.29M | -35.1M | -38.42M | -42.05M | -40.66M | -37.88M | -40.09M | -47.74M | -44.85M | -39.89M | -51.5M | -57.59M | -43.44M | -37.13M | -58.39M | -52.79M |